Prostate cancer is one of the most common cancers affecting men around the world. In many countries, including Germany, it is the most frequently diagnosed cancer in men. Each year, about 65,000 men ...

Prostate tumors contain more microplastics than healthy prostate tissue, researchers from New York University Langone Health ...

Artificial intelligence has bounded into the mainstream, into personal lives, classroom assignments and work meetings — so it ...

New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY® ...

The research lays a foundation for the possibility that aggressive prostate cancer can probably be detected through a few drops of semen or blood in the long term. Prostate cancer is the most common ...

About 60% of low‑risk prostate cancer patients are opting for active surveillance — and long‑term survival remains high.

Bayer AG (BAYRY) announced an update on their ongoing clinical study. The CHINANEO trial is a Phase 2 Bayer study in China testing how well a combo of darolutamide and hormone therapy works before ...

MINNEAPOLIS, March 5, 2026 /PRNewswire/ — Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical trial) ...

Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for ...

New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY (piflufolastat F 18) with the potential for larger batches and greater pati ...

Robert F. Kennedy Jr. and his subordinates want Americans to have more conversations with their physicians. But they also can ...

DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), ...